Compare Edwards Lifesciences Corporation Common Stock (EW) vs iShares MSCI Japan ETF (EWJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs iShares MSCI Japan ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while iShares MSCI Japan ETF trades at $97.4 (market cap $24.21B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 2× iShares MSCI Japan ETF's market cap, and iShares MSCI Japan ETF is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | EWJ | |
|---|---|---|
Market Cap | $49.44B | $24.21B |
Volume | 3,508,027 | 2,672,665 |
Sector | Health | Broad Market / Factor |
52-Week High | $95.18 | $99.32 |
52-Week Low | $72.65 | $78.36 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 56 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
EWJ, the iShares MSCI Japan ETF, trades at $98.32, down 1.01% amid broader Asian market volatility. Technical indicators show a bullish moving average signal but neutral oscillators, with key support at $97 and resistance at $99. Recent news highlights Japan's monetary policy uncertainty as the BOJ navigates rate hikes and yen intervention efforts, creating both opportunities and risks for Japan-focused investors.
The outlook for EWJ remains cautiously optimistic given Japan's economic stimulus efforts and AI sector growth potential, though rising bond yields and currency volatility present significant headwinds. Investors should monitor BOJ policy decisions and yen stability as key catalysts for near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About iShares MSCI Japan ETF
EWJ tracks the MSCI Japan Index, providing broad exposure to over 180 large and mid-cap companies in Japan. It is the most established and liquid vehicle for accessing the Japanese equity market, featuring a diversified portfolio across industrials, consumer discretionary, and financial sectors.
Read more on EWJ →
